PHOENIX (PRWEB) February 22, 2018
The innovators at Aesthetics Biomedical announce that Cartessa Aesthetics will be the exclusive US distributor for The Vivace, a state-of-the-art, best-in-class FDA-cleared microneedling RF device. Cartessa has been part of the successful marketing effort for the best-in-class device for nearly one year.
The demand for microneedling in cosmetic surgeons' and doctors' offices is on the rise with a record number of services performed across the industry last year. The Vivace combines this highly sought-after service with radio frequency which tightens the skin and reduces wrinkles, and the treatment is enhanced with an incomparable patient experience, a signature offering of ABM. Setting The Vivace apart from the competition are a number of design decisions made in the best interest of patient results and patient comfort.
"The success of our partnership with Cartessa is rooted in our shared values and vision. Cartessa understands the potential of this technology as it relates to patient outcomes and accelerated ROI for physicians. We are very proud of the great reception The Vivace has received in the marketplace, and Cartessa has the distribution expertise to maximize its success. This relationship will allow more practices and patients to have access to The Vivace Experience and its superior outcomes. Our expanded relationship will set a new paradigm of success," says MaryAnn Guerra, CEO for Aesthetics Biomedical.
"Our relationship with Aesthetics Biomedical is a pivotal one. ABM was one of our first partners and having The Vivace in our portfolio exemplified what Cartessa was founded to do-identify and distribute the best-in-class technologies that optimize the patient experience. We look forward to our expanded relationship with ABM and to helping make The Vivace a household name nationwide," says Gabe Lubin, founder and CEO Cartessa Aesthetics. "Patients are looking for the best results with minimal disruption to their daily life, and The Vivace delivers exactly that. We've had practices go from doing virtually zero microneedling to doing several Vivace treatments each day, so it's been a win for all involved" says Lubin.
The Vivace has many key distinctions from its competitors, but most of all it's the most comfortable patient experience with no downtime and immediate results. Patients say that they feel a sensation on their skin that tells them the device is doing its job. Testimonials immediately following treatment, one month after treatment and one year after treatment continue to showcase the real results from The Vivace.
"We are bullish on getting the word out about The Vivace Experience so that more physicians may offer this quality aesthetic procedure. Our intent is to put a dent in the high consumer demand for an outstanding treatment that creates immediate as well as ongoing results but won't cause patients to miss a moment of their active lives. With this new exclusive distributorship, we can make that happen," says Guerra.
ABOUT AESTHETICS BIOMEDICAL
Aesthetics Biomedical, Inc. is an international aesthetics innovation company headquartered in Phoenix, Ariz., uniquely offering procedure and product enhancement, development, clinical indication, expansion, application optimization, FDA clearance expertise and worldwide distribution. Aesthetics Biomedical's innovation center is a leader in breakthrough technologies and multiple source combination therapies for its clients, physician network and the aesthetic arena. http://www.aestheticsbiomedical.com
ABOUT CARTESSA AESTHETICS
Cartessa Aesthetics, LLC sources leading aesthetic medical devices for distribution to dermatologists, plastic surgeons, cosmetic physicians and medical spas. Cartessa selects the most cutting-edge technologies that offer clinically proven efficacy, patient safety, and the best possible investment for patients and professionals. All products within Cartessa's portfolio are FDA-cleared. http://www.cartessaaesthetics.com.